cZNF292 is found to suppress glioma cells proliferation and vascularization by reducing the expression of cellular Cyclin A, p-CDK2, CDK2, β-catenin, p-STAT3(Tyr705) and p-STAT5 (Tyr694). This evidence concerns the gene CDK2 and glioma.